Loading…
Lobbying Spend
—
Filings
31
Firms Hired
2
Active Period
2015–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Elijah E. Cummings Lower Drug Costs Now Act
2021 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
2021 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4502
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022
2021 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.3062
Medicare Drug Price Negotiation Act
2021 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.908
Prescription Drug Price Relief Act of 2021
2021 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.909
Affordable and Safe Prescription Drug Importation Act
2021 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.920
Elijah E. Cummings Lower Drug Costs Now Act
2021 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
2021 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.4502
Medicare Drug Price Negotiation Act
2021 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.908
Prescription Drug Price Relief Act of 2021
2021 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.909
Affordable and Safe Prescription Drug Importation Act
2021 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.920
Elijah E. Cummings Lower Drug Costs Now Act
2021 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3
Medicare Drug Price Negotiation Act
2021 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.908
Prescription Drug Price Relief Act of 2021
2021 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.909
Affordable and Safe Prescription Drug Importation Act
2021 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act.
Client expense: — · Firm income: $30,000
Matched citations: S.920
Medicare Drug Price Negotiation Act
2021 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.
Client expense: — · Firm income: $30,000
Matched citations: S.908
Prescription Drug Price Relief Act of 2021
2021 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.
Client expense: — · Firm income: $30,000
Matched citations: S.909
Affordable and Safe Prescription Drug Importation Act
2021 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology; COVID-19 therapies; drug pricing; FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.
Client expense: — · Firm income: $30,000
Matched citations: S.920
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.133
Patient Protection and Affordable Care Enhancement Act
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.1425
Lower Costs, More Cures Act of 2019
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.19
Elijah E. Cummings Lower Drug Costs Now Act
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.3
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.7614
Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.7617
Continuing Appropriations Act, 2021 and Other Extensions Act
2020 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Client expense: — · Firm income: $50,000
Matched citations: H.R.8337
Source: Senate LDA